Physician profile
John Kuchar
NPI 1477554962
$463.05
in general payments reported to CMS, 2019-2025
12 companies · $74.19 in 2025
The $74.19 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2021: $43.27 · 2022: $18.04 · 2023: $41.55 · 2024: $90.43 · 2025: $74.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $134.13 | 2019 | |
| Sumitomo Pharma America, INC. | $83.15 | 2024-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $47.18 | 2019-2023 | Lynparza, Keytruda |
| Endo USA, INC. | $34.69 | 2024-2025 | Aveed, Xiaflex |
| Tempus Ai, INC | $29.17 | 2025 | Xt Cdx |
| Heron Therapeutics, INC. | $23.73 | 2021 | |
| Mallinckrodt Enterprises LLC | $21.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.51 | 2023 | |
| Acacia Pharma INC | $19.54 | 2021 | |
| Antares Pharma, INC. | $18.04 | 2022 | |
| Teleflex LLC | $17.61 | 2024 | Urolift |
| Ge Healthcare | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kuchar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.